Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Valiant Laboratories Ltd. (VALIANTLAB) Stock Price & Analysis

0 Followers

VALIANTLAB Stock Chart & Stats

₹107.45-₹2.15(-1.96%)
At close: 3:30 PM GMT+5:30
₹75₹100₹125Aug 17Aug 31Sep 15Sep 28Oct 12Oct 26Nov 9
Day’s Range
INR 107.45 - INR 107.45
52-Week Range
INR 47.60 - INR 141.30
Previous Close
INR 109.60
Volume
N/A
Average Volume (3M)
5,005
Market Cap
INR 5.95B
Enterprise Value
INR 6.88B
Total Cash (Recent Filing)
INR 369.49M
Total Debt (Recent Filing)
INR 377.84M
Price to Earnings (P/E)
35.9
Beta
0.29
Next Earnings
Feb 14, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Revenue Recovery

The FY2026 revenue rebound demonstrates renewed demand after a difficult two-year period and restores operating scale across the API business. If sustained, stronger sales can improve fixed-cost absorption, support customer continuity, and provide a foundation for rebuilding profitability.

Modest Leverage

The large equity base relative to debt indicates modest leverage and gives the company a more stable financial structure than a heavily indebted peer. This supports resilience through operating volatility and preserves flexibility to fund facilities, compliance, or other business needs.

Growing Asset Base

An expanding asset base suggests that the company has built greater operating scale and resource capacity over time. That infrastructure can support higher API volumes and future revenue recovery, provided management improves the returns generated from those assets.

Bears Say

Persistent Losses

The shift from sustained earlier profits to losses in the two latest fiscal years shows that the current business model is not converting revenue into dependable earnings. Continued losses can weaken internally generated capital and make future investment increasingly dependent on external funding.

Cash Burn

Negative operating cash flow means the company is not currently generating cash from its core operations, while deeply negative free cash flow indicates a substantial funding requirement after investment. If this persists, liquidity and capital allocation flexibility may remain under pressure.

Weak Operating Profitability

Near-break-even EBIT reveals very limited operating margin despite the revenue rebound, leaving little buffer against cost changes or weaker demand. The collapse from earlier profitability also indicates that earnings quality and margin sustainability remain materially weaker than the company’s historical peak.

Valiant Laboratories Ltd. News

VALIANTLAB FAQ

What was Valiant Laboratories Ltd.’s price range in the past 12 months?
Valiant Laboratories Ltd. lowest stock price was ₹47.60 and its highest was ₹141.30 in the past 12 months.
What is Valiant Laboratories Ltd.’s market cap?
Valiant Laboratories Ltd.’s market cap is ₹5.95B.
When is Valiant Laboratories Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Valiant Laboratories Ltd.’s earnings last quarter?
Valiant Laboratories Ltd. released its earnings results on Nov 02, 2026. The company reported ₹0.076 earnings per share for the quarter.
Is Valiant Laboratories Ltd. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Valiant Laboratories Ltd. pay dividends?
Valiant Laboratories Ltd. does not currently pay dividends.
What is Valiant Laboratories Ltd.’s EPS estimate?
Valiant Laboratories Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Valiant Laboratories Ltd. have?
Valiant Laboratories Ltd. has 54,312,500 shares outstanding.
What happened to Valiant Laboratories Ltd.’s price movement after its last earnings report?
Valiant Laboratories Ltd. reported an EPS of ₹0.076 in its last earnings report. Following the earnings report the stock price went down -1.486%.
Which hedge fund is a major shareholder of Valiant Laboratories Ltd.?
Currently, no hedge funds are holding shares in IN:VALIANTLAB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology